The challenge is that a group of people are going to profit massively from this drug being approved. Some patients are going to pay $56K+ on this treatment, in

The challenge is that a group of people are going to profit massively from this drug being approved. Some patients are going to pay $56K+ on this treatment, in other cases, we taxpayers are going to pay that (Medicare/Medicaid). Should this be approved if it's ineffective?